All Stories

  1. Vaccination in paroxysmal nocturnal hemoglobinuria patients treated with terminal and proximal complement inhibitors — Polish Expert Consensus
  2. Influenza vaccination as part of the cardiovascular prevention — expert opinion supported by the Working Group on Cardiovascular Pharmacotherapy and Working Group on Prevention and Epidemiology Section of the Polish Cardiac Society
  3. Infections in Young Elite Athletes: Risks, Impacts and Prevention
  4. Expert Opinion: A Call for Early and Appropriate Symptomatic Treatment in Acute Respiratory Infections to Prevent Escalation
  5. Recurrent course of Kawasaki disease with cardiac and joint complications – a case report
  6. Both Corticosteroids and Intravenous Immunoglobulin Protect From Aneurysms in Children With Multisystem Inflammatory Syndrome (MIS-C): A Multicenter Ambispective Study
  7. Influenza prevention among hospital employees in Poland – a narrative review
  8. Development of lactation and breast/chestfeeding adverse event terminology (LaBAET) through a Delphi consensus approach
  9. Neurodevelopmental Outcomes in Children with Neonatal Parechovirus CNS Infections
  10. The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease
  11. A randomised trial of pleuran in paediatric acute gastroenteritis
  12. Dilemmas in HHV-6-associated neurological diseases
  13. Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025
  14. 2024 update on meningococcal vaccination recommendations for children and adults
  15. Recommendations of Polish experts for 2024 on the co-administration of vaccines in adults for the prevention of respiratory infections
  16. Indications for computed tomography of the head in children following head trauma: shortcomings in the NICE, CATCH, SIGN, PECARN, and CHALICE guidelines
  17. RSV prevention in adults: consensus of experts of Polish scientific societies
  18. Vaccination against shingles. Recommendations of a group of experts from Polish scientific societies – update 2025
  19. The changing epidemiology of tick-borne encephalitis: epidemic surveillance and disease prevention challenges
  20. Antibiotics Usage and Avoidance in Germany and Poland: Attitudes and Knowledge of Patients, Physicians, and Pharmacists
  21. Gender matters, especially if you are a Polish teenager being examined by a doctor or a doctor examining a teenager
  22. Treatment outcomes and their predictors in children hospitalized with varicella complicated by bacterial superinfections after pandemic of COVID-19 – a retrospective multicenter analysis of real-life data in Poland
  23. Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systemati...
  24. How international guidelines recommend treating children who have severe COVID‐19 or risk disease progression
  25. The anti-infective effect of β-glucans in children
  26. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023
  27. The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel
  28. Improving Vaccine Assessment Pathways and Decision Making in the Polish Immunization Program
  29. Pathologic Analysis of Twenty-one Appendices From Children With Multisystem Inflammatory Syndrome Compared to Specimens of Acute Appendicitis: A Cross-sectional Study
  30. Towards better protection of older people against influenza and its complications. Polish recommendations for HD influenza vaccine
  31. Stanowisko Zarządu Polskiego Towarzystwa Wakcynologii i Prezesa Polskiego Towarzystwa Pediatrycznego w sprawie realizacji szczepień podstawowych przeciw błonicy, tężcowi i krztuścowi u dzieci w wieku powyżej 3 lat
  32. Kiedy wybieram nystatynę w zawiesinie – u jakich pacjentów i w jakich sytuacjach klinicznych warto po nią sięgnąć?
  33. Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season
  34. Sepsis-like HPeV encephalitis in young infants – case series
  35. Ukrainian War Refugee Children With Particularly Severe Viral Infections: A Case Series Report
  36. The role of pneumococcal vaccination in reducing cardiovascular risk in cardiac patients: Expert opinion of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society
  37. Non-cardiac sequelae of Kawasaki Disease. The survey study of 90 cases and literature review
  38. Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
  39. Respiratory Syncytial Virus Infections in Polish Pediatric Patients from an Expert Perspective
  40. Monte Carlo Regression for Evaluating Children’s Role in the Pandemic Spread on the Example of Delta COVID-19 Wave
  41. The impact of childhood febrile urinary tract infection on urinary tract dilation in ultrasonography
  42. Life-threatening non-angioneurotic swelling of the tongue as a complication of frenotomy in an eight-year-old boy
  43. Guidelines of the Polish Society of Gynecologists and Obstetricians, the Polish Society for Vaccinology, and the Polish Society for Family Medicine on vaccinating women with reproductive plans and pregnant or breastfeeding women
  44. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
  45. Influenza vaccination from the perspective of health care workers at university hospitals
  46. Potential Saving of Antibiotics for Respiratory Infections in Several European Countries: Insights from Market Research Data
  47. Three-Dimensional Echocardiography and Global Longitudinal Strain in Follow-up after MIS-C
  48. The Influence of SARS-CoV-2 Variants B.1.1.7 and B.1.617.2 on a Different Clinical Course and Severity of COVID-19 in Children Hospitalized in 2021 Compared With 2020
  49. Clinical Course and Severity of COVID-19 in 940 Infants with and without Comorbidities Hospitalized in 2020 and 2021: The Results of the National Multicenter Database SARSTer-PED
  50. In vitro dissolution test of ketoprofene: development and evaluation of release from soft and hard gelatine capsules
  51. Response to the letter to the Editor regarding the article “Vaccine versus infection - COVID-19-related loss of training time in elite athletes”
  52. Adult pneumococcal vaccination – new opportunities
  53. Herbal medicinal products in RESPIRATORY diseases – STANce of the Polish PHYTOtherapy Association – STANPHYTO RESPIRATORY I
  54. Herbal medicinal products in RESPIRATORY diseases – STANce of the Polish PHYTOtherapy Association – STANPHYTO RESPIRATORY II
  55. Dobre praktyki w szczepieniach – rekomendacje dla POZ w zakresie szczepień ochronnych dzieci i młodzieży
  56. Vaccine or Garlic–Is It a Choice? Awareness of Medical Personnel on Prevention of Influenza Infections
  57. Upper respiratory tract infections and influenza-like illnesses among healthcare workers: are serological tests useful in monitoring influenza and influenza-like illness?
  58. Vaccine versus infection – COVID-19-related loss of training time in elite athletes
  59. Coalition Shaping the Vaccination Landscape
  60. Newborn screening and gene therapy in SMA: Challenges related to vaccinations
  61. Exposure to non-opioid analgesics during pregnancy and the risk of adverse drug reactions
  62. Analysis of 21 appendices from children with multisystem inflammatory syndrome compared to specimens of acute appendicitis – a new insight into MIS-C pathology
  63. Sports Elite Means Vaccine Elite? Concerns and Beliefs Related to COVID-19 Vaccines among Olympians and Elite Athletes
  64. A tendency to worse course of multisystem inflammatory syndrome in children with obesity: MultiOrgan Inflammatory Syndromes COVID-19 related study
  65. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome
  66. Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study
  67. Effects of Non-Opioid Analgesics on the Cell Membrane of Skin and Gastrointestinal Cancers
  68. Streptococcus intermedius Acute Meningitis in an Immunocompetent Child
  69. COVID-19 infections in infants
  70. Authors’ response to Dr Finsterer's comment “Exclude differentials before diagnosing SARS-CoV-2-associated acute hemorrhagic necrotizing encephalitis” (THEIJID-D-22-00008)
  71. Post-exposure prophylaxis in cases of injury – rules of conduction
  72. The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with Covid-19.
  73. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
  74. Treatment of Autoinflammatory Diseases
  75. Anti-Inflammatory Therapy of Infections
  76. Non-Cardiac Sequelae of Kawasaki Disease in 3 Months Follow Up Period
  77. Elite athletes with COVID-19 — Predictors of the course of disease
  78. Guidelines for immunization of children following multisystem inflammatory syndrome in children
  79. Pneumococcal vaccination among adults – updated Polish recommendations
  80. Recommendations of the Polish Paediatric Society, the Polish Society of Vaccinology, and the Polish Society of Family Medicine on meningococcal vaccinations in children and adults in Poland
  81. Updated principles of prevention, diagnosis and treatment of COVID-19 in children in Poland – recommendations for paediatricians and family medicine doctors
  82. Orchiepididymitis in a 14-year-old boy with concurrent SARS-CoV-2 infection
  83. COVID-19 immunizations in occupational medicine
  84. Distinct characteristics of multisystem inflammatory syndrome in children in Poland
  85. Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic—Results of the Pediatric Part of a Multicenter Polish Register SARSTer
  86. Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19—analysis of a paediatric part of Polish register SARSTer
  87. Recurrent assessment of lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS‐C)
  88. An Infant With Seborrhoeic Dermatitis and Eczema Herpeticum Complicated by a Generalized Infection
  89. A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir
  90. Multisystem inflammatory syndrome in European White children – study of 274 cases
  91. The Impact of a Single Educational Lecture on the Vaccine Confidence among Pregnant Women and Young Mothers
  92. Protocol of the study: the effectiveness of pleuran in the treatment of acute gastroenteritis in children—a randomised, placebo-controlled, double-blind trial (EPTAGE)
  93. Epidemiology, diagnosis, and prevention of tick-borne encephalitis in Poland and selected european countries – a position statement of the polish group of experts
  94. Fever and Diarrhea as the Only Symptoms of Multisystem Inflammatory Syndrome in Children
  95. ASSESSMENT OF SAFETY OF PAIN CONTROL BY NON-OPIOID OVER-THE COUNTER MEDICATIONS
  96. Cutaneous larva migrans in a beach volleyball player
  97. SARS-CoV-2 Cluster in Nursery, Poland
  98. Approach to a child with Multisystem Inflammatory Syndrome associated with COVID19. Recommendations by the Polish Paediatric Society Expert Group. Update – February 2021
  99. Recommendations for primary healthcare doctors for the management of acute respiratory infections in children during the SARS-CoV-2 pandemic – COVID COMPASS
  100. Streptococcal sepsis and periorbital cellulitis as a complication of influenza in a 4-year-old girl
  101. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register
  102. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland
  103. Development of child immunity in the context of COVID-19 pandemic
  104. Kleszczowe zapalenie mózgu u 9-letniego chłopca – choroba, której można było uniknąć
  105. A 16-year-old boy with severe lumbar pain
  106. Vaccinations in rheumatic diseases
  107. A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention
  108. Safety and Impact on Training of the Influenza Vaccines in Elite Athletes Participating in the Rio 2016 Olympics
  109. Recommendations for the prevention, diagnosis and treatment of inFLUenza in adults for Primary care physiciAnS: FLU COMPAS PCP – ADULTS
  110. The clinical course of gastroenteritis due to nosocomial and community acquired norovirus infections in immunocompromised and immunocompetent children – single center experience
  111. Vesicular rash in a 5-year-old boy with dyspnoea
  112. Acute renal failure due to leptospirosis. Diagnostic challenges – a case report
  113. Antibiotic usage at a clinical paediatric hospital before and after the implementation of actions related to the hospital antibiotic policy
  114. Spleen: Consequences of Lack of Function
  115. THE USE OF OTC HERBAL SEDATIVES BY PHARMACY PATIENTS – A QUESTIONNAIRES-BASED SURVEY STUDY
  116. Atypical course of varicella-zoster infection in a child with acute lymphoblastic leukaemia
  117. Severe Hyponatremia in a 6-month-old Infant
  118. Przeczucie matki czy ocena lekarzy? Przypadek siedmiomiesięcznego niemowlęcia z gorączką
  119. Zapalenie opon mózgowo-rdzeniowych wywołane przez meningokoki serogrupy B – opis przypadku oraz analiza medycznego zdarzenia niepożądanego
  120. Decreasing Vaccination Coverage Against Hepatitis B and Tuberculosis in Newborns
  121. Autologous Platelet-Rich Plasma Reduces Healing Time of Chronic Venous Leg Ulcers: A Prospective Observational Study
  122. Genetic Predisposition for Osteoporosis and Fractures in Postmenopausal Women
  123. ReCOMmendations for the treatment of INFLUENZA in children for Primary care physiciAnS – COMPAS INFLUENZA
  124. Vaccination Against Measles, Mumps, and Rubella in the Light of Current Epidemic Threats: Unjustified Postponement
  125. Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries
  126. Treatment of acute pharyngitis
  127. Impact of European vaccination policies on seasonal influenza vaccination coverage rates: an update seven years later
  128. Response to Letter to the Editor re ‘Urinary tract infection in children: Diagnosis, treatment, imaging – Comparison of current guidelines’
  129. Hyperbaric Oxygen Therapy (HBOT) in Pediatrics
  130. Leczenie przeciwwirusowe grypy
  131. Antibody Response to Trivalent Influenza Vaccine in the Northern and the Southern Hemisphere in Elite Athletes
  132. Knowledge Regarding Influenza and Influenza Vaccination in General Population: Results of a National Survey in Poland
  133. Urinary tract infection in children: Diagnosis, treatment, imaging – Comparison of current guidelines
  134. Spleen: Disorders
  135. Non-specific signs of neuroinfection after a tick bite in a 10-year-old boy – a case report
  136. Benign Acute Childhood Myositis During Influenza B Outbreak
  137. Evaluation of the Implementation of Hospital Antibiotic Policy in Oncosurgery Ward: A Six-Year Experience
  138. Healthcare Professionals’ Knowledge of Influenza and Influenza Vaccination: Results of a National Survey in Poland
  139. Pertussis outbreak in Polish shooters with adverse event analysis
  140. Public Perception of the Risks Associated with Infectious Diseases in Poland: Ebola and Influenza and Their Impact on the Attitude to Vaccination
  141. Rapid Influenza Diagnostic Tests Improve Suitability of Antiviral Treatment in Hospitalized Children
  142. Three episodes of Kawasaki disease including one after the Pneumo 23 vaccine in a child with a family history of Kawasaki disease
  143. Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands
  144. Clinical Presentation of Herpes Zoster in Immunocompetent and Immunocompromised Hospitalized Children Treated With Acyclovir
  145. Zika virus infection – a new epidemic threat
  146. Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections
  147. Awareness of Influenza and Attitude Toward Influenza Vaccination Among Medical Students
  148. Gastroesophageal Reflux Disease in Children with Interstitial Lung Disease
  149. Pertussis: History of the Disease and Current Prevention Failure
  150. Rapid Influenza Diagnostic Tests - Indications, Clinical Implications and Usefulness
  151. Current recommendations regarding vaccinations in asplenia and hyposplenia
  152. Safety of Oral Clemastine – Analysis of Data from Spontaneous Reporting System in Poland
  153. Incidence and Clinical Course of Respiratory Viral Coinfections in Children Aged 0–59 Months
  154. Usage of Over-the-Counter and Herbal Products in Common Cold in Poland: Findings from Consumer Survey
  155. Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections
  156. Implementation of Hospital’s Antibiotic Policy Decreases Antimicrobial Use in the General Pediatric Ward
  157. Microbiological Spectrum and Susceptibility Pattern of Clinical Isolates from the Neonatal Unit in a Single Medical Center
  158. Stagnating Low Influenza Vaccine Coverage Rates in the Polish Elderly Population in 2008–2013
  159. The Incidence of Respiratory Tract Infections in Vertically HIV-Infected Children in Lower Silesia in Poland and the Approach to Infection Prevention
  160. Safety of Oral Paracetamol – Analysis of Data from a Spontaneous Reporting System in Poland
  161. Respiratory Tract Infections in Children in Primary Healthcare in Poland
  162. Quality of Life and Health Care Utilization in Patients with Chronic Respiratory Diseases
  163. Antibiotic Consumption Pattern in the Neonatal Special Care Unit Before and After Implementation of the Hospital’s Antibiotic Policy
  164. Epidemiological and Clinical Reasons for Vaccination Against Pertussis and Influenza in Pregnant Women
  165. Immunizations Against Respiratory Infections in Children in Primary Health Care in Poland: Coverage and Delays
  166. PERTUSSIS AS HEALTH CARE WORKERS INFECTIOUS DISEASE - THE CLINICAL CASE WITH A COMMENTARY
  167. The Clinical Course of Late Diagnosed Fatal Cases of A (H1N1) Influenza in Poland
  168. Pandemic influenza in the 2009/2010 season in central Poland: The surveillance study of laboratory confirmed cases
  169. Immunopathology of exercise-induced bronchoconstriction in athletes — A new modified inflammatory hypothesis
  170. Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults
  171. Etiology and Complications of Central Nervous System Infections in Children Treated in a Pediatric Intensive Care Unit in Poland
  172. Complicated course of facial cellulitis caused by Staphylococcus aureus in a 13-year-old boy with neutropenia — an adverse event analysis
  173. Immunization Coverage Against Capsular Bacteria in Splenectomized Patients
  174. Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010
  175. Respiratory Complications in Children Hospitalized with Varicella
  176. Liver steatosis in Polish children assessed by medicolegal autopsies
  177. Epidemiology of Pertussis in an Urban Region of Poland: Time for a Booster for Adolescents and Adults
  178. Influence of Rapid Influenza Test on Clinical Management of Children Younger than Five with Febrile Respiratory Tract Infections
  179. Influenza Immunization Rates in Children and Teenagers in Polish Cities: Conclusions from the 2009/2010 Season
  180. Nosocomial Rotovirus Gastroenetrocolitis in Children Hospitalized Primarily Due to Respiratory Infections
  181. Surgical Treatment of Neurologic Complications of Bacterial Meningitis in Children in Kosovo
  182. Mortality From Bacterial Meningitis in Children in Kosovo
  183. Medycyna podróży w Internecie – porady dla pediatrów, jak korzystać z polskiego i anglojęzycznego Internetu z podaniem wiarygodnych stron
  184. Early symptomatic and late seizures in Kosovar children with bacterial meningitis
  185. Clinical manifestations of influenza caused by A/H1N1v virus among children and teenagers consulted in general practice
  186. Influenza vaccine coverage among children under the age of 5 years in Poland during 2004-2008